NCT00296257View on ClinicalTrials.gov

Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114

PHASE2TerminatedINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

April 30, 2008

Conditions
Rheumatoid Arthritis (RA)
Interventions
DRUG

SMP-114

Trial Locations (46)

1815

JD Alkmaar

3078

Rotterdam

3923

Zerbst

9713

Groningen

31134

Hildesheim

40882

Ratingen

61231

Bad Nauheim

79106

Freiburg im Breisgau

470 01

Česká Lípa

370 00

České Budějovice

748 01

Hlučín

722 00

Ostrava Trebovice

128 50

Prague

158 00

Prague

411 55

Terezín

686 01

Uherské Hradiště

760 01

Zlín

04103

Leipzig

H5600

Békéscsaba

H 1023

Budapest

H1023

Budapest

H 4004

Debrecen

H 4043

Debrecen

H2500

Esztergom

H6000

Kecskemét

Unknown

Komárom

Częstochowa

H 3529

Miskolc

H 9700

Szombathely

82-300

Elblag

40-635

Katowice

20-022

Lublin

81-759

Sopot

26-200

Swietokrzyce

71-252

Szczecin

00-909

Warsaw

02-637

Warsaw

B29 6JD

Birmingham

CO4 5JL

Colchester

PA16 0XN

Greenock

HD3 3EA

Huddersfield

SE5 9PJ

London

ME16 9QQ

Maidstone

CH49 5PE

Metropolitan Borough of Wirral

TS4 3BW

Middlesbrough

NE7 7DN

Newcastle Upon Tyne and Wear

Sponsors
All Listed Sponsors
lead

Dainippon Sumitomo Pharma Europe LTd.

INDUSTRY